2026-11-19 02:13:25
TLC-KY's TLC599 Presents Joint Protection Data at ACR Conference on November 10
According to TLC-KY, the company's knee osteoarthritis drug TLC599 presented clinical findings at the American College of Rheumatology Convergence 2026 on November 10. The study, conducted in collaboration with University of Arizona Professor C. Kent Kwoh, showed that TLC599 may protect cartilage an